Federal award
FLOW PHARMA, INC.
W911QY20C0057
ContractSBIR/STTR ST2
Obligated and Ceiling
- Obligated (net)
- $999,980.00
- Ceiling (potential value, not spending)
- $999,980.00
- Current value
- $999,980.00
- Gross positive obligations
- $999,980.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- FLOW PHARMA, INC. · JPU1CSU7D998
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- FLOW PHARMA, INC. · J3DJA4HJPQF1
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AD25 · R&D- DEFENSE OTHER: SERVICES (OPERATIONAL SYSTEMS DEVELOPMENT)
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- W911QY20C0057
- Award type code
- D
- Actions
- 5 · May 12, 2020 to Mar 15, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 15, 2023 | FY2023 | P00003 | M | $0.00 | — |
| Feb 17, 2023 | FY2023 | A00001 | M | $0.00 | — |
| Feb 17, 2022 | FY2022 | P00002 | M | $0.00 | — |
| Aug 25, 2021 | FY2021 | P00001 | D | $462,510.00 | — |
| May 12, 2020 | FY2020 | 0 | — | $537,470.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.